# Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) – FDA Inspection, Mar 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/c4db414c-686b-4498-a4b8-2022ce9c30ef
Source feed: FDA_Inspections

> FDA inspection 1261674 of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant), March 14, 2025. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261674
- Company Name: Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- Inspection Date: 2025-03-14
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1084107 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/98b9736f-c6d4-4c5c-9113-69846725a990)
- FDA Inspection 981968 - 2016-07-22
- FDA Inspection 866095 - 2013-12-20
- FDA Inspection 582495 - 2009-04-23

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)
- [Company Rep](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)

Company: https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
